Last edition
News about "Pharma 2025 Profit Forecast"
AbbVie Cuts 2025 Profit Forecast Following USD 2.7 Billion R&D Charge
The company plans to reduce its adjusted earnings per share guidance to a range of USD 10.38 to USD 10.58, down from its prior forecast of USD 11.88 to USD 12.08.
Pharma 2025 Profit Forecast | 06/10/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members